0.49% -0.0045

Seres Therapeutics Inc (MCRB)

Seres Therapeutics Inc 주식(MCRB)의 최신 뉴스

Seres Therapeutics Inc (MCRB)

Seres Therapeutics Inc 주식(MCRB)의 최신 뉴스

Seres Therapeutics executive sells shares worth $792 By Investing.com - Investing.com

Seres Therapeutics executive sells shares worth $837 By Investing.com - Investing.com

Seres Therapeutics executive sells shares worth $837 By Investing.com - Investing.com Canada

Seres Therapeutics executive sells shares worth $882 - Investing.com ZA - Investing.com South Africa

Seres Therapeutics executive sells shares worth $882 By Investing.com - Investing.com

Seres Therapeutics CEO sells $2,288 in stock By Investing.com - Investing.com Canada

Seres Therapeutics CEO sells $2,288 in stock By Investing.com - Investing.com

Seres Therapeutics executive sells shares worth $660 - Investing.com India

Seres Therapeutics executive sells shares worth $660 - Investing.com ZA - Investing.com South Africa

Seres Therapeutics executive sells shares worth $660 By Investing.com - Investing.com

Seres Therapeutics (NASDAQ:MCRB) Shares Cross Above 50 Day Moving Average of $0.82 - MarketBeat

Seres Therapeutics (NASDAQ:MCRB) Shares Cross Above 50 Day Moving Average of $0.82 - Defense World

Earnings call: Seres Therapeutics reports on Q1 2024 with VOWST updates - Investing.com

Earnings call: Seres Therapeutics reports on Q1 2024 with VOWST updates - Investing.com India

Seres Therapeutics (MCRB) Q3 Earnings and Revenues Beat Estimates - Yahoo New Zealand News

Seres Therapeutics, Inc. (NASDAQ:MCRB) Q1 2024 Earnings Call Transcript - Insider Monkey

Chardan Capital Lowers Seres Therapeutics (NASDAQ:MCRB) Price Target to $6.00 - Defense World

Seres Therapeutics (NASDAQ:MCRB) Price Target Cut to $4.00 by Analysts at Oppenheimer - MarketBeat

Seres Therapeutics (MCRB) in Focus: Stock Up 5.5% in Session - Yahoo Movies Canada

Seres Therapeutics stock target cut amid sales dip - Investing.com Canada

Seres Therapeutics Inc (MCRB) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights and Financial ... - GuruFocus.com

Seres Therapeutics shares target cut by Oppenheimer amid sales dip - Investing.com Canada

Seres Therapeutics stock target cut amid sales dip - Investing.com India

Seres Therapeutics First Quarter 2024 Earnings: US$0.28 loss per share (vs US$0.56 loss in 1Q 2023) - Yahoo Finance

Seres Therapeutics (NASDAQ:MCRB) Price Target Cut to $4.00 by Analysts at Oppenheimer - MarketBeat

Seres Therapeutics at Risk of Nasdaq Delisting: A Race Against Time to Bolster Stock Value - TipRanks.com - TipRanks

Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates - citybiz

Seres Therapeutics Reports Q1 2024 Earnings: Surpasses Revenue Estimates - GuruFocus.com

Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates - 08.05.2024 - wallstreet:online

Seres Therapeutics: Q1 Earnings Snapshot - Milford Mirror

Seres Therapeutics (MCRB) Set to Announce Quarterly Earnings on Wednesday - MarketBeat

Analysts Are Betting On Seres Therapeutics, Inc. (NASDAQ:MCRB) With A Big Upgrade This Week - Yahoo Movies Canada

Seres Therapeutics (MCRB) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Lifestyle Australia

Seres Therapeutics (MCRB) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Lifestyle UK

Increases to Seres Therapeutics, Inc.'s (NASDAQ:MCRB) CEO Compensation Might Cool off for now - Yahoo Finance

Institutional owners may take dramatic actions as Seres Therapeutics, Inc.'s (NASDAQ:MCRB) recent 25% drop adds to one-year losses - Simply Wall St

Chardan Capital Comments on Seres Therapeutics, Inc.'s FY2024 Earnings (NASDAQ:MCRB) - MarketBeat

Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2023 Earnings Call Transcript - Yahoo Finance

Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Wednesday

Earnings call: Seres Therapeutics reports promising VOWST launch - Investing.com

A New Cause for Concern: Seres Therapeutics Inc. Adds a New Supply Chain Risk - TipRanks.com - TipRanks

Pamela Stephenson to head commercial at Disc - BioCentury

Seres Therapeutics Announces Executive Leadership Transition and New CFO Compensation Details - TipRanks.com - TipRanks

Seres Therapeutics appoints new CFO as Arkowitz retires - Investing.com

MCRB Stock Quote Price and Forecast - CNN

Seres Therapeutics Announces 2024 Virtual Stockholders Meeting - TipRanks.com - TipRanks

Halozyme Therapeutics (HALO) Surges 5.6%: Is This an Indication of Further Gains?

Dow Tumbles Over 200 Points; US Trade Gap Narrows In November

Seres Therapeutics, Inc. (NASDAQ:MCRB) is a favorite amongst institutional investors who own 62% - Yahoo Finance

Seres: Evaluating Vowst's Market Challenges (Rating Downgrade) (NASDAQ:MCRB) - Seeking Alpha

MCRB과 유사한 종목